Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug;15(4):335-342.
doi: 10.1007/s11914-017-0375-y.

Melorheostosis: a Rare Sclerosing Bone Dysplasia

Affiliations
Review

Melorheostosis: a Rare Sclerosing Bone Dysplasia

Anupam Kotwal et al. Curr Osteoporos Rep. 2017 Aug.

Abstract

Purpose of review: Melorheostosis is a rare sclerosing bone dysplasia that affects both cortical bone and adjacent soft tissue structures in a sclerotomal distribution. In this review, we describe the natural history, radiological features, proposed pathogenesis, and management options for this debilitating condition.

Recent findings: Since its first description in 1922, about 400 cases of melorheostosis have been reported, either as single reports or in small case series. Melorheostosis affects the appendicular skeleton more commonly than the axial skeleton and usually presents with lower limb deformity. Diagnosis is based on a combination of clinical and radiological features that help differentiate this condition from other sclerosing bone dysplasias. LEM domain-containing protein 3 (LEMD3) gene mutations have been demonstrated in several familial cases, but these have been more strongly correlated with other hereditary dysplasias, such as osteopoikilosis, and are not thought to be the causative gene for melorheostosis. The exact etiology of classic sporadically occurring melorheostosis remains unknown, with possible causes being somatic LEMD3 mutations, somatic mutations in the bone morphogenetic protein/transforming growth factor-beta pathway, mutations in multiple genes, or other non-genetic causes. Management in recent years has involved nitrogen-containing bisphosphonates in addition to traditional orthopedic surgical approaches and physical therapy. Melorheostosis may present as mixed or atypical osseous involvement in addition to the classically described "dripping candle wax" appearance of hyperostosis. Some patients may have overlap with osteopoikilosis or Buschke-Ollendorff syndrome. In the future, better characterization of genetic and developmental factors predisposing to melorheostosis may lead to the development of targeted therapy for this condition, as well as for more commonly encountered skeletal abnormalities.

Keywords: Bone dysplasia; Hyperostosis; Melorheostosis; Sclerotomal distribution.

PubMed Disclaimer

References

    1. Foot Ankle Int. 2005 Aug;26(8):660-3 - PubMed
    1. Br J Radiol. 1991 Jan;64(757):60-2 - PubMed
    1. Hum Mutat. 2006 Mar;27(3):290 - PubMed
    1. Clin Radiol. 2010 Aug;65(8):593-600 - PubMed
    1. Can Assoc Radiol J. 1999 Oct;50(5):324-30 - PubMed

MeSH terms

LinkOut - more resources